Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: Ther Drug Monit. 2017 Oct;39(5):556–564. doi: 10.1097/FTD.0000000000000427

Table 3.

Summary of CDPHE [38] study sample results.

Compound THC 11OH-THC THC-COOH THC-C-gluc

Matrix Plasma Urine Plasma Urine Plasma Urine Plasma Urine
No. of negative 256 92 254 89 146 32 160 12
No. of positive 96 1 98 4 206 61 192 81
Max. concentration [ng/mL] 57.8 0.8 300.2 132.8 391.5 309.8 1495.1 7431.0
Compound CBD CBN CBC CBG

Matrix Plasma Urine Plasma Urine Plasma Urine Plasma Urine
No. of negative 198 88 351 93 292 92 345 92
No. of positive 154 5 1 0 60 1 7 1
Max. concentration [ng/mL] 344.1 3.3 2.1 0.0 18.3 1.2 1.2 1.0
Compound THCV THCV-COOH CBDV

Matrix Plasma Urine Plasma Urine Plasma Urine
No. of negative 347 93 308 66 351 91
No. of positive 5 0 44 27 1 2
Max. concentration [ng/mL] 1.6 0.0 17.8 81.3 2.0 2.4